	普通株資本		日付
Acadia Pharmaceuticals	USD 171.09M	1.9M	2026-03
Adma Biologics	USD 232.29M	5.59M	2026-03
ALKERMES	USD 167.54M	1.08M	2026-06
Alterity Therapeutics Limited	AUD 10.88B	10.66B	2025-12
AstraZeneca	USD 1.55B	44K	2026-06
BioCryst Pharmaceuticals	USD 255.26M	42.2M	2026-06
Bristol-Myers Squibb	USD 2.04B	1.74B	2025-09
Cipla	INR 807.78M	17K	2026-03
Clal Biotechnology	ILS 1.61M	0	2022-12
Compugen	USD 94.55M	1000	2026-03
CSL	USD 482.13M	93.87M	2025-12
Eli Lilly	USD 943.5M	3.33M	2026-03
GlaxoSmithKline	GBP 4.08B	20.6M	2026-06
Grifols	EUR 680.58M	846.11K	2025-12
Halozyme Therapeutics	USD 114.04M	4.48M	2026-06
Ionis Pharmaceuticals	USD 165.64M	265K	2026-06
J&J	USD 2.41B	1.35M	2026-03
Merck	USD 2.47B	4.93M	2026-03
Minerva Neurosciences	USD 1000	0	2024-09
Neurocrine Biosciences	USD 100.55M	50K	2026-06
Novartis	USD 1.9B	7.38M	2026-06
Novavax	USD 162.58M	106K	2025-12
Pfizer	USD 5.7B	0	2026-06
Roche Holding	CHF 796.77M	1.15M	2026-06
Sanofi	EUR 1.21B	8.25M	2026-03
Takeda	JPY 1.58B	460K	2026-06
Vanda Pharmaceuticals	USD 58K	0	2024-12